Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.63+0.51 (+8.33%)
Close on Nov 12, 2026Market cap $99.34MP/E –Yield –
Cumberland Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cumberland Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -34.9%. For fiscal 2025 it was -6.4%, against -17.1% the year before. The highest annual figure on record is 834.6% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.4% | +10.7 |
| FY2024 | Dec 31, 2024 | -17.1% | −1.2 |
| FY2023 | Dec 31, 2023 | -15.9% | −2.6 |
| FY2022 | Dec 31, 2022 | -13.3% | −3.5 |
| FY2021 | Dec 31, 2021 | -9.7% | −0.8 |
| FY2020 | Dec 31, 2020 | -8.9% | +1.4 |
| FY2019 | Dec 31, 2019 | -10.3% | +13.4 |
| FY2018 | Dec 31, 2018 | -23.7% | −4.3 |
| FY2017 | Dec 31, 2017 | -19.4% | −16.5 |
| FY2016 | Dec 31, 2016 | -2.9% | −84.1 |
| FY2015 | Dec 31, 2015 | 81.3% | −322.7 |
| FY2014 | Dec 31, 2014 | 404.0% | +667.0 |
| FY2013 | Dec 31, 2013 | -263.1% | −1097.7 |
| FY2012 | Dec 31, 2012 | 834.6% | +823.6 |
| FY2011 | Dec 31, 2011 | 11.1% | +5.7 |
| FY2010 | Dec 31, 2010 | 5.4% | −1.7 |
| FY2009 | Dec 31, 2009 | 7.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2569.0% | −2374.5 |
| Q1 FY2026 | Mar 31, 2026 | -36.0% | −46.8 |
| Q4 FY2025 | Dec 31, 2025 | -10.3% | +7.9 |
| Q3 FY2025 | Sep 30, 2025 | -23.4% | −6.4 |
| Q2 FY2025 | Jun 30, 2025 | -194.5% | −183.5 |
| Q1 FY2025 | Mar 31, 2025 | 10.7% | +33.6 |
| Q4 FY2024 | Dec 31, 2024 | -18.2% | +49.1 |
| Q3 FY2024 | Sep 30, 2024 | -17.0% | −6.6 |
| Q2 FY2024 | Jun 30, 2024 | -11.0% | −19.0 |
| Q1 FY2024 | Mar 31, 2024 | -22.9% | −25.0 |
| Q4 FY2023 | Dec 31, 2023 | -67.3% | −40.5 |
| Q3 FY2023 | Sep 30, 2023 | -10.4% | −6.8 |
| Q2 FY2023 | Jun 30, 2023 | 8.0% | +21.0 |
| Q1 FY2023 | Mar 31, 2023 | 2.1% | +14.5 |
| Q4 FY2022 | Dec 31, 2022 | -26.8% | +19.5 |
| Q3 FY2022 | Sep 30, 2022 | -3.6% | +9.5 |
| Q2 FY2022 | Jun 30, 2022 | -13.0% | −26.5 |
| Q1 FY2022 | Mar 31, 2022 | -12.4% | −14.0 |
| Q4 FY2021 | Dec 31, 2021 | -46.2% | −37.6 |
| Q3 FY2021 | Sep 30, 2021 | -13.1% | −7.9 |
| Q2 FY2021 | Jun 30, 2021 | 13.6% | +23.1 |
| Q1 FY2021 | Mar 31, 2021 | 1.6% | +14.3 |
| Q4 FY2020 | Dec 31, 2020 | -8.6% | +1.7 |
| Q3 FY2020 | Sep 30, 2020 | -5.2% | +23.0 |
| Q2 FY2020 | Jun 30, 2020 | -9.6% | −3.7 |
| Q1 FY2020 | Mar 31, 2020 | -12.7% | −11.8 |
| Q4 FY2019 | Dec 31, 2019 | -10.3% | +6.1 |
| Q3 FY2019 | Sep 30, 2019 | -28.2% | −8.8 |
| Q2 FY2019 | Jun 30, 2019 | -5.8% | +1.3 |
| Q1 FY2019 | Mar 31, 2019 | -0.8% | +26.9 |
| Q4 FY2018 | Dec 31, 2018 | -16.4% | −9.6 |
| Q3 FY2018 | Sep 30, 2018 | -19.3% | −12.7 |
| Q2 FY2018 | Jun 30, 2018 | -7.1% | +52.5 |
| Q1 FY2018 | Mar 31, 2018 | -27.7% | −14.5 |
| Q4 FY2017 | Dec 31, 2017 | -6.9% | +1.4 |
| Q3 FY2017 | Sep 30, 2017 | -6.6% | −7.8 |
| Q2 FY2017 | Jun 30, 2017 | -59.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -13.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -8.3% | – |
| Q3 FY2016 | Sep 30, 2016 | 1.2% | – |
See a number that looks wrong?